Cosmo Pharmaceuticals N.V.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Cosmo Pharmaceuticals N.V.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 9% to $92,780,000. Profit margin reached -5%. Total operating expenses were $47,294,000.
Profit Margin
| 2014 | 79.59M | 73.32M | 92.12% |
|---|---|---|---|
| 2015 | 60.60M | 248.19M | 409.51% |
| 2016 | 67.66M | 19.34M | 28.58% |
| 2017 | 67.24M | -32.44M | -48.25% |
| 2018 | 65.61M | -18.05M | -27.52% |
| 2019 | 62.49M | -24.49M | -39.19% |
| 2020 | 60.94M | -7.90M | -12.96% |
| 2021 | 65.07M | 21.67M | 33.3% |
| 2022 | 102.08M | 17.22M | 16.87% |
| 2023 | 92.78M | -4.93M | -5.32% |
0RGI.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 92.78M | 102.08M | 65.07M | 60.94M | 62.49M | 65.61M | 67.24M | 67.66M | 60.60M | 79.59M |
Cost of revenue | 39.34M | 18.76M | 15.14M | 10.44M | 9.24M | 12.37M | 12.12M | 10.18M | 10.07M | 11.62M |
Gross profit | 53.44M | 83.32M | 49.93M | 50.50M | 53.24M | 53.24M | 55.11M | 57.47M | 50.53M | 67.97M |
Operating exp. | ||||||||||
Research and development | 18.81M | 15.52M | 11.35M | 13.59M | 15.69M | 0 | 9.09M | 0 | 28.68M | 24.82M |
Selling and marketing | 602K | 419K | 339K | 337K | 5.24M | 9.90M | 9.47M | 140K | 47K | 1.53M |
Total operating expenses | 47.29M | 55.27M | 38.83M | 43.6M | 65.55M | 69.86M | 64.72M | 32.08M | 55.96M | 45.75M |
Operating income | 6.14M | 28.05M | 33.11M | 2.05M | -12.30M | -16.62M | -15.49M | 21.00M | 250.30M | 22.21M |
Other income (expenses), net | -4.61M | -3.58M | -9.11M | -13.83M | -8.99M | -838K | -16.93M | 6.48M | 3.98M | 86.63M |
Income before tax | 1.53M | 24.47M | 24.00M | -6.93M | -21.30M | -17.45M | -32.43M | 27.49M | 254.29M | 108.85M |
Income tax expense | 6.26M | 6.96M | 2.33M | 970K | 3.19M | 598K | 15K | 8.15M | 6.09M | 35.52M |
Net income | -4.93M | 17.22M | 21.67M | -7.90M | -24.49M | -18.05M | -32.44M | 19.34M | 248.19M | 73.32M |
Earnings per share | ||||||||||
Basic EPS | -0.31 | 1.05 | 1.29 | -0.55 | -1.67 | -1.2 | -2.19 | 1.37 | 17.6 | 5.12 |
Diluted EPS | -0.31 | 1.05 | 1.28 | -0.55 | -1.67 | -1.2 | -2.19 | 1.17 | 17.05 | 5.03 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |